References
- Abreu AC, McBain AJ, Simoes M. 2012. Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep. 29:1007–1021.
- Alanis AJ. 2005. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res. 36:697–705.
- An J, Zuo GY, Hao XY, Wang GC, Li ZS. 2011. Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Phytomedicine 18:990–993.
- Andremont A, Bonten M, Kluytmans J, Carmeli Y, Cars O, Harbarth S. 2011. Fighting bacterial resistance at the root: need for adapted EMEA guidelines. Lancet Infect Dis. 11:6–8.
- Bassetti M, Nicco E, Mikulska M. 2009. Why is community-associated MRSA spreading across the world and how will it change clinical practice? Int J Antimicrob Agents. 34:S15–S19.
- Borges-Argáez R, Balnbury L, Flowers A, Giménez-Turba A, Ruiz G, Waterman PG, Peña-Rodríguez LM. 2007. Cytotoxic and antiprotozoal activity of flavonoids from Lonchocarpus spp. Phytomedicine 14:530–533.
- Bruchhaus I, Roeder T, Rennenberg A, Heussler VT. 2007. Protozoan parasites: programmed cell death as a mechanism of parasitism. Trends Parasitol. 23:376–383.
- Casey AL, Lambert PA, Elliot TS. 2007. Staphylococci. Int J Antimicrob Agents. 29:S23–S32.
- Chan BCL, Ip M, Lau CBS, Lui SL, Jolivalt C, Ganem-Elbaze C, Litaudon M, Reiner NE, Gong HS, See RH, et al. 2011. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. J Ethnopharmacol. 137:767–773.
- Clinical and Laboratory Standards Institute (CLSI). 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 8th ed. Wayne (PA): CLSI. (DocumentM7-A8).
- Cortázar TM, Coombs GH, Walker J. 2007. Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine. Exp Parasitol. 475–482.
- Eumkeb G, Chukrathok S. 2013. Synergistic activity and mechanism of action of ceftazidime and apigenin combination against ceftazidime-resistant Enterobacter cloacae. Phytomedicine 20:262–269.
- Eumkeb G, Sakdarat S, Siriwong S. 2010. Reversing β-lactam antibiotic resistance of Staphylococcus aureus with galangin from Alpinia officinarum Hance and synergism with ceftazidime. Phytomedicine 18:40–45.
- Eumkeb G, Siriwong S, Thumanu K. 2012. Synergistic activity of luteolin and amoxicillin combination against amoxicillin-resistant Escherichia coli and mode of action. J Photochem Photobiol B Biol. 117:247–253.
- European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2000. Terminology relating to methods for determination of susceptibility of bacteria to antimicrobial agents. Clin Microbiol Infect. 6:503–508.
- French GL. 2010. The continuing crisis in antibiotic resistance. Int J Antimicrob Agents. 36:S3–S7.
- Fujita M, Shiota S, Kuroada T, Hatano T, Yoshida T, Mizushima T, Tsuchiya T. 2005. Remarkable synergies between baicalein and tetracycline, and baicalein and beta-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol. 49:391–396.
- Galzi JL, Hachet-Haas M, Bonnet D, Daubeuf F, Lecat S, Hibert M, Haiech J, Frossard N. 2010. Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications. Pharmacol Therapeut. 126:39–55.
- Hošek J, Závalová V, Šmejkal K, Bartoš M. 2010. Effect of diplacone on LPS-induced inflammatory gene expression in macrophages. Folia Biol. (Praha) 56:124–130.
- Jean-Moreno V, Rojas R, Goyeneche D, Coombs GH, Walker J. 2006. Leishmania donovani: differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays. Exp Parasitol. 112:21–30.
- Kollár P, Bárta T, Závalová V, Šmejkal K, Hampl A. 2011. Geranylated flavanone tomentodiplacone B inhibits proliferation of human monocytic leukaemia (THP-1) cells. Br J Pharmacol. 162:1534–1541.
- Kurinčič M, Klančnik A, Smole Možina S. 2012. Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics. Int J Antimicrob Agents. 40:467–471.
- Muzitano MF, Tinoco LW, Guette C, Kaiser CR, Rossi-Bergmann B, Costa SS. 2006. The antileishmanial activity assessment of unusual flavonoids from Kalanchoe pinnata. Phytochemistry 67:2071–2077.
- Navrátilová A, Schneiderová K, Veselá D, Hanáková Z, Fontana A, Dall'Acqua S, Cvačka J, Innocenti G, Novotná J, Urbanová M, et al. 2013. Minor C-geranylated flavanones from Paulownia tomentosa fruits with MRSA antibacterial activity. Phytochemistry 89:104–113.
- Nešuta O, Lopez-Aban J, Shariati F, Yepes E, Navrátilová A, Šmejkal K, Žemlička M, Muro A. 2011. Polyphenols as inhibitors of NO production in LPS-stimulated rat macrophages. J Nat Pharm. 2:15–19.
- Nour AM, Khalid SA, Kaiser M, Brun R, Abdalla WE, Schmidt TJ. 2010. The antiprotozoal activity of methylated flavonoids from Ageratum conyzoides L. J Ethnopharmacol. 129:127–130.
- Nový P, Rondevaldová J, Kouřimská L, Kokoška L. 2013. Synergistic interactions of epigallocatechin gallate and oxytetracycline against various drug resistant Staphylococcus aureus strains in vitro. Phytomedicine 20:432–435.
- Radwan MM, El Sohly MA, Slade D, Ahmed SA, Wilson L, El-Alfy AT, Khan IA, Ross SA. 2008a. Non-cannabinoid constituents from a high potency Cannabis sativa variety. Phytochemistry 69:2627–2633.
- Radwan MM, Ross SA, Slade D, Ahmed SA, Zulfiqar F, Elsohly MA. 2008b. Isolation and characterization of new cannabis constituents from a high potency variety. Planta Med. 74:267–272.
- Rocha LG, Almeida JRGS, Macêdo RO, Barbosa-Filho JM. 2005. A review of natural products with antileishmanial activity. Phytomedicine 12:514–535.
- Rodríguez-Rojas A, Rodríguez-Beltrán J, Couce A, Blázquez J. 2013. Antibiotics and antibiotic resistance: a bitter fight against evolution. Int J Med Microbiol. 303: 293–297.
- Sakagami Y, Mimura M, Kajimura K, Yokoyama H, Linuma M, Tanaka T, Ohyama M. 1998. Anti-MRSA activity of sophoraflavanone G and synergism with other antibacterial agents. Lett Appl Microbiol. 27:98–100.
- Salem MM, Capers J, Rito S, Werbovetz KA. 2011. Antiparasitic activity of C-geranyl flavonoids from Mimulus bigelovii. Phytother Res. 25:1246–1249.
- Salem MM, Werbovetz KA. 2006. Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis. Curr Med Chem. 13:2571–2598.
- Sato M, Tanaka H, Yamaguchi R, Kato K, Etoh H. 2004. Synergistic effects of mupirocin and an isoflavanone isolated from Erythrina variegata on growth and recovery of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 24:241–246.
- Sen N, Das BB, Ganguly A, Banerjee B, Sen T, Majumder HK. 2006. Leishmania donovani: intracellular ATP level regulates apoptosis-like death in luteolin induced dyskinetoplastid cells. Exp Parasitol. 114:204–214.
- Šmejkal K, Chudík S, Klouček P, Marek R, Cvačka J, Urbanová M, Julínek O, Kokoška L, Šlapetová T, Holubová P, et al. 2008. Antibacterial C-geranylflavonoids from Paulownia tomentosa fruits. J Nat Prod. 71:706–709.
- Sudano Roccaro A, Blanco AR, Giuliano F, Rusciano D, Enea V. 2004. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob Agents Chemother. 48:1968–1973.
- Varela-M RE, Villa-Pulgarin JA, Yepes E, Müller I, Modolell M, Muñoz DL, Robledo SM, Muskus CE, López-Abán J, Muro A, et al. 2012. In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites. PLoS Negl Trop Dis. 6:e1612. doi:10.1371/journal.pntd.0001612.
- Wagner H, Ulrich-Merzenich G. 2009. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 16:97–110.
- Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T. 2001. Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin resistant Staphylococcus aureus. Antimicrob Agents Chemother. 45:1737–1742.